Latest News

  • July 25, 2017  JRS Specialty Products Facility in China Awarded EXCiPACT Certification

    JRS PHARMA is pleased to announce that its Star-Tech & JRS Specialty Products excipients manufacturing site in Chongqing, China, has been awarded EXCiPACT certification.
  • April 24, 2017  JRS PHARMA Announces New Laboratory in Brazil

    JRS PHARMA has announced the upcoming grand opening of a new laboratory located at their Diadema, Brazil location. The lab is scheduled to be opened during JRS PHARMA’s Latin America Technical Seminar on June 26-27, 2017.
  • February 22, 2017  JRS PHARMA Expands their Product Portfolio with the Addition of the Povidone Family

    JRS PHARMA Expands their Product Portfolio with the Addition of the Povidone Family
    JRS PHARMA has announced the worldwide release of the Povidone Family product line, the latest addition to their excipients portfolio. This product line consists of three products: VIVAPHARM® PVP (Povidone), VIVAPHARM® PVP/VA 64 (Copovidone), and VIVAPHARM® PVPP (Crospovidone).
  • August 18, 2016  JRS PHARMA Now Direct in India

    JRS PHARMA products can now be purchased direct in India. All business has been transferred from S. Zhaveri Pharmakem Pvt. Ltd. to Rettenmaier India Pvt. Ltd., a wholly owned subsidiary of the JRS Group ( J. RETTENMAIER & Söhne)
  • July 20, 2016  JRS PHARMA to Offer Povidone Products

    JRS PHARMA, headquartered in Germany, has entered into a joint venture agreement with SSP, headquartered in Chongqing, China, for the commercialization of povidone products. The new JV company is Star-Tech & JRS Specialty Products.
  • March 21, 2016  New Dextrates Facility Construction Nearing Completion in Cedar Rapids, IA

    JRS Pharma continues to expand and advance our manufacturing capabilities. We are pleased to share that the construction of our new manufacturing facility for dextrates products will soon be complete.
  • February 29, 2016  Michael Hampel Named New CEO of JRS PHARMA LP

    We are excited to announce that Michael Hampel has been named the new CEO of our North American Pharma division.
Stay Connected.     LinkedIn  Youtube 

Copyright 2017, JRS PHARMA - All Rights Reserved